Loss of heterozygosity in CCM2 cDNA revealing a structural variant causing multiple cerebral cavernous malformations.
Annabelle ChaussenotXavier AyrignacNicolas ChatronTerry Granchon-RiolzirPierre LabaugeElisabeth Tournier-LasserveFlorence RiantPublished in: European journal of human genetics : EJHG (2024)
Loss-of-function variants in CCM1/KRIT1, CCM2/MGC4607, and CCM3/PDCD10 genes are identified in the vast majority of familial cases with multiple cerebral cavernous malformations. However, genomic DNA sequencing combined with large rearrangement screening fails to detect a pathogenic variant in 5% of the patients. We report a family with two affected members harboring multiple CCM lesions, one with severe hemorrhages and one asymptomatic. No causative variant was detected using DNA sequencing of the three CCM genes, CNV detection analysis, and RNA sequencing. However, a loss of heterozygosity in CCM2 was observed on cDNA sequences in one of the two affected members, which strongly suggested that this locus might be involved. Whole genome sequencing (WGS) identified a balanced structural variant on chromosome 7 with a breakpoint interrupting the CCM2 gene, preventing normal mRNA synthesis. These data underline the importance of WGS in undiagnosed patients with typical multiple CCM.
Keyphrases
- copy number
- single cell
- genome wide
- end stage renal disease
- circulating tumor
- chronic kidney disease
- early onset
- newly diagnosed
- ejection fraction
- gene expression
- genome wide identification
- cell free
- peritoneal dialysis
- transcription factor
- artificial intelligence
- prognostic factors
- drug induced
- patient reported outcomes
- data analysis